TM
SNTI icon

Triatomic Management’s Senti Biosciences Holdings SNTI Stock Holding History

Triatomic Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,549
Closed -$4.28K – 4
2024
Q2 		$4.28K Sell
1,549
-29,504
-95% -$95.6K 0.13% 7
2024
Q1 		$117K Hold
31,053
– – 0.22% 23
2023
Q4 		$205K Hold
31,053
– – 0.26% 32
2023
Q3 		$128K Buy
31,053
+1,000
+3% +$6.88K 0.09% 48
2023
Q2 		$188K Buy
30,053
+8,965
+43% +$87.5K 0.19% 45
2023
Q1 		$249K Buy
21,088
+5,920
+39% +$92.1K 0.17% 45
2022
Q4 		$214K Buy
15,168
+9,523
+169% +$232K 0.18% 42
2022
Q3 		$123K Buy
+5,645
New +$111K 0.07% 47

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Triatomic Management's SNTI Position: Q3 2024 in Review

Triatomic Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2024, closing a stake of 1,549 shares — an estimated $4.28K sold.

Triatomic Management first reported a position in SNTI in Q3 2022 and held it in 8 quarters. The position peaked at $249K in Q1 2023. 14 funds tracked by Wall St. Rank hold SNTI as of Q3 2024.

  • Triatomic Management reported no remaining Senti Biosciences Holdings position as of Q3 2024 after selling out during the quarter.
  • Triatomic Management sold 1,549 Senti Biosciences Holdings shares in Q3 2024, an estimated $4.28K.
  • Triatomic Management first reported a position in Senti Biosciences Holdings in Q3 2022 and held it in 8 quarters.
  • Triatomic Management's Senti Biosciences Holdings position peaked at $249K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2024.

Based on Triatomic Management's 13F filing for Q3 2024.